Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Study: Reflexion's Virtual Physical Therapy Reduces Costs

Virtual physical therapy from San Diego-based Reflexion Health was effective as traditional therapy while saving money, according to a first-of-its-kind clinical trial conducted by Duke Clinical Research Institute.

Ionis, Roche Strengthen Ties with Deal Worth Up to $759M

Swiss drug giant Roche and Carlsbad’s Ionis Pharmaceuticals seem increasingly enamored with one another.

New Palomar CEO Takes on Financial, Medical And Staffing Challenges

The word “interim” in a job title implies caretaker. Not to Diane Hansen, evidently.

Tease photo

Xenco Medical CEO Named to California Workforce Development Board

Jason Haider, the CEO of San Diego-based Xenco Medical, has been appointed by Gov. Jerry Brown to the California Workforce Development Board.

Ionis Gets Good News With FDA Approval

Ionis Pharmaceuticals’ drug for a rare genetic disorder recently gained regulatory approval, a relief to investors worried about a denial, and pitting the company against Alnylam Pharmaceuticals.

Tease photo

AMN Healthcare Says HQ Will Remain Local

San Diego’s AMN Healthcare is not relocating to Dallas, ending speculation raised by the CEO’s new home and twin datelines.

Tease photo

MappBio Wins Contract To Combat Viruses

San Diego’s MappBio recently received a $14.8 million contract to advance a treatment for Sudan virus.

Scripps Research Adds Board of Overseers

Scripps Research added a 21-member Board of Overseers with big names from across San Diego life sciences as the organization broadens its scope, it was recently announced.

UC San Diego to Open New Rancho Bernardo Facility

UC San Diego Health on Oct. 15 will open a 57,000-square-foot Rancho Bernardo center with offerings spanning primary care, urgent care and behavioral health.

Institutes Take Cues From Business for Funding

FINANCE: Quest for Private Money Brings New Models, Partnerships

UC San Diego’s drug research arm in recent years took a new tack with investors and pharmaceuticals: Tell us what we’re doing wrong.

Tease photo

Sharp Grossmont Hospital’s Burr Heart & Vascular Center Opens

Burr Heart & Vascular Center at Sharp Grossmont Hospital – per Sharp the only dedicated cardiovascular center in East County -- recently began treating patients.

With Drug Approval, Ionis Set to Compete with Alnylam

The U.S. Food and Drug Administration on Oct. 5 approved Ionis Pharmaceuticals’ drug for a potentially fatal genetic disorder, pitting the company against Alnylam Pharmaceuticals.

Biotechs Among Most Impacted by Gender Law

LEGAL: Women Often Bypassed On Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Tease photo

Medtechs Lead Life Science Stock Gains for Third Quarter

Medtechs led the way in stocks of public life science companies in San Diego during the third quarter.

Tease photo

MappBio Awarded $14.8M Contract for Sudan Virus Therapy

San Diego’s MappBio received a $14.8 million contract to advance a treatment for Sudan virus.

Biotechs Among Most Impacted by Law Requiring Women on Boards

LEGAL: Dearth of Women on Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Frances Arnold, an Illumina Board Member, Shares Nobel Prize

The board director of San Diego life sciences giant Illumina and professor at Caltech shared in the Nobel Prize for Chemistry.

Tease photo

Acadia and FDA Confident in Parkinson’s Psychosis Drug

Acadia Pharmaceuticals is flying higher after the U.S. Food and Drug Administration reaffirmed its drug in uncharacteristically public fashion.

VelosBio Lands $58M Round

VelosBio, a San Diego-based firm developing cancer drugs, received a $58 million Series A round, investor Arix Bioscience recently announced.

Careful Approach to CBD Sales Paying Off

CANNABIS: Products Tested; Co. Also Working on New Drug

CV Sciences has emerged as a major player of a burgeoning corner of the cannabis industry: hemp-derived cannabidiol.

Tease photo

Ra Medical Raises $66.3M in Trading Debut

Carlsbad’s Ra Medical Systems became a public company on Sept. 27, raising $66.3 million.

Life Sciences Reporter's Notebook: Life Sciences Loads Up on VC Dollars

In San Diego, life sciences dominates in early-stage investment. Looking at 2017 through this September — a 19-month period — San Diego-based life sciences companies pulled in $2.73 billion in venture capital, according to a recently released snapshot from JLL research. That represented 44.8 percent of venture capital in San Diego, more than the next three categories combined.

Tease photo

Tocagen Hires Head of Commercial Role

Tocagen, a San Diego company behind a cancer therapy that’s in a final-stage trial, is building up commercial operations.

Rady Children’s Launches Medi-Cal Pilot for Genetic Testing in Newborns

Rady Children’s Hospital recently announced its lead role in a state pilot program that will expand genome sequencing for critically ill newborns.

Epic Aims to ‘Revolutionize Cancer Care’

MEDICINE: Extending Lives, Cutting Waste Are Part of Goals

Epic Sciences’ pitch: greater certainty.

Tease photo

Vital Therapies Lays Off 83 Employees After Clinical Trial

After halting a treatment for acute liver failure, Vital laid off 83 employees, according to a state notice.

FDA Fast-Track Designation for Cidara Therapeutics

San Diego-based Cidara Therapeutics gained fast-track status from the U.S. Food and Drug Administration for its lead drug candidate aimed at preventing invasive fungal infections, the company announced Sept. 25.

Medical System Wants To Be Housing Provider

HEALTH: Plans Aim to Cut Congestion, Fund Infrastructure

Long a provider of housing for university students, UC San Diego is now pushing for dwellings for employees of its medical system.

Tease photo

Equillium Prepares $86M IPO

La Jolla-based Equillium intends to raise $86 million through an initial public offering, according to recently filed U.S. Securities and Exchange Commission paperwork.

La Jolla Vein Care Adds Space

La Jolla Vein Care – which treats vein disease and disorders – recently doubled its clinic space.

ICYMI: Ex-Illumina Leaders Form Own Cos. To Pursue Genomics Work

Kevin Gunderson was employee No. 7 of 6,000 at Illumina. He led the company’s advanced research group for almost 18 years, helping create its first $1 billion product line.

Tease photo

Ionis’ Huntington’s Drug Heads to Final-Stage Trial

Medications can help manage symptoms of Huntington’s disease. But invariably sufferers are robbed of mental and physical abilities.

Tease photo

Life Sciences Reporter's Notebook: Heron Hoping for A Political Solution

The U.S. Senate on Sept. 17 passed bipartisan legislation to combat the opioid epidemic. For at least one San Diego biotech, a notable measure was missing.

Acadia’s Stock Surges on FDA Reaffirming Drug

The U.S. Food and Drug Administration didn’t find new safety concerns after reexamining Acadia Pharmaceutical’s drug to treat hallucinations and delusions caused by Parkinson’s disease.

Alliance Healthcare Foundation Awards $2M to Local Organizations

San Diego-based Alliance Healthcare Foundation established has a new $2 million fund with the San Diego Foundation. That money will be split between the Multicultural Health Foundation and Somali Family Services.

Life Sciences Reporter's Notebook: Clearity Marks 10 Years in Ovarian Cancer Fight

Laura Shawver — perhaps best known as the CEO of Synthorx — launched the Clearity Foundation after her own experience with ovarian cancer.

Tease photo

Samumed Inks Licensing Deal Worth Up To $350M

United Therapeutics Corporation gained North American licensing rights to a lung disease drug from San Diego’s Samumed in a deal announced Sept. 17.

Illumina’s Progress Creates Encouraging Ecosystem for Others

In 2000, the cost to sequence a genome stood at $100 million.

Tease photo

ViaCyte Set to Receive $15M in Diabetes Collaboration

ViaCyte, a San Diego stem cell therapy biotech, has teamed up with a Massachusetts gene-editing company to take on diseases like diabetes.

Sherpa Clinical Packaging Acquired

San Diego-based Sherpa Clinical Packaging has been acquired by PCI Pharma Services under a deal announced Sept. 11 in which terms were not disclosed.

Vital Therapies Abandons Liver Treatment After Clinical Trial

San Diego’s Vital Therapies on Sept. 12 scrapped a cell-based therapy intended to treat acute liver failure following final-stage clinical trials, sending the company’s stock plummeting.

Epic Sciences Pulls in $52M Series E Round

Epic Sciences on Sept. 12 hauled in a $52 million Series E round to advance a portfolio of tests.

Exagen Diagnostics Launches Blood Test for Managing Rheumatoid Arthritis

Vista-based Exagen Diagnostics launched a blood test for added insight in managing rheumatoid arthritis.

Co. Takes on Dementia By Making Memories

HEALTH: Tablets Bring Life Stories to Treatment

A man with dementia in a San Diego care facility uttered little. But upon holding a tablet with rotating images of his hometown of Chicago, he beamed. Words flowed.

Tease photo

Ramping up its Commercial Strategy, Halozyme Hires a CCO

Halozyme Therapeutics hired pharmaceutical veteran Benjamin Hickey as the company’s chief commercial officer, it was recently announced.

Sharp Blames Actions By Agency for Its Exit of Accountable Care Organization

HEALTH: Sharp Says Moves By CMS Changed Savings to a Loss

Sharp HealthCare is considering its legal options after earlier this year withdrawing from a Medicare program in which health systems shoulder greater accountability.

$65 Million Pledged for UCSD Drug Development Partnership

A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.

ResMed Files Lawsuit Over Alleged Patent Infringements

A patent dispute between ResMed and Fisher & Paykel Healthcare has escalated.

Tease photo

Gary and Mary West Foundation Helps Establish Not-For-Profit Generic Drug Co.

San Diego’s Gary and Mary West Foundation is helping get off the ground Civica RX, a new not-for-profit generic drug company with the goal of tackling shortages and high prices on life-saving medications.

Gossamer Lures Former Bristol-Myers Squibb Executive as CSO

San Diego-based Gossamer Bio, which in July snagged a $230 million series B round, recently announced the hire of a former executive from pharmaceutical giant Bristol-Myers Squibb.

Prev